Why Medifast's $15 Cash Per Share Makes It A Strong Buy
Medifast: Worth Putting On A Watchlist
Medifast Q1 Earnings Call Highlights
Medifast, Inc. Q1 2026 Earnings Call Summary
Medifast (MED) Q1 2026 Earnings Transcript
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
Medifast (NYSE:MED) Q1 Loss Narrower Than Feared as Coach Productivity Improves
Medifast (NYSE:MED) Delivers Impressive Q1 CY2026
Medifast Announces First Quarter 2026 Financial Results
Medifast, Inc. 2026 Q1 - Results - Earnings Call Presentation
Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
Medifast Affirms FY2026 GAAP EPS Guidance of $(2.75)-$(1.55) vs $(1.98) Est; Affirms FY2026 Sales Guidance of $270.000M-$300.000M vs $273.700M Est
Medifast Sees Q2 GAAP EPS $(1.00)-$(0.50) vs $(0.43) Est; Sees Sales $60.000M-$80.000M vs $74.700M Est
Medifast Q1 EPS $(0.19) Beats $(0.52) Estimate, Sales $76.044M Beat $69.200M Estimate
Medifast (MED) Q1 Earnings: What To Expect
Medifast's Q1 Earnings on The Horizon: Key Insights for Investors
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026
We Think MEDICLIN's (ETR:MED) Solid Earnings Are Understated
3 Reasons MED is Risky and 1 Stock to Buy Instead
1 Small-Cap Stock with Exciting Potential and 2 We Find Risky
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.